MLchartDataset catalogue

Taurultam analogue GP-2250

Term · Oncology and biomedicine · MLC-T-ONC-016994

An oxathiazine-based structural analogue of taurultam (TRLT), which is the main derivative of the anti-infective agent taurolidine (TRD), with potential antineoplastic activity. Upon administration, GP-2250 selectively induces reactive oxygen species (ROS)-mediated apoptosis in and inhibits proliferation of susceptible tumor cells.

Table 1. Record
IdentifierMLC-T-ONC-016994
FieldOncology and biomedicine
Synonymssubstance 2250
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016994",
  "term": "Taurultam analogue GP-2250",
  "field": "Oncology and biomedicine",
  "definition": "An oxathiazine-based structural analogue of taurultam (TRLT), which is the main derivative of the anti-infective agent taurolidine (TRD), with potential antineoplastic activity. Upon administration, GP-2250 selectively induces reactive oxygen species (ROS)-mediated apoptosis in and inhibits proliferation of susceptible tumor cells.",
  "synonyms": [
    "substance 2250"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/taurultam-analogue-gp-2250/"
}

Record 16,012 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.